Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA grants IND clearance for Phase I/IIa trial of Skyline’s SKG0106
In December last year, SKG0106 entered clinical trials in humans for neovascular or wet age-related macular degeneration indications. Credit: Amanda Dalbjörn on Unsplash.
In December last year, SKG0106 entered clinical trials in humans for neovascular or wet age-related macular degeneration indications. Credit: Amanda Dalbjörn on Unsplash.